Results 261 to 270 of about 108,133 (341)

Preoperative Use of Glucagon-Like Peptide-1 Receptor Agonists Is Not Protective Against Pseudoarthrosis Following Small Joint Hand Arthrodesis: A Propensity-Matched Analysis. [PDF]

Hand (N Y)
Stump K, Morar H, Talsania A, Centeno D, Wiekrykas B.   +4 more
europepmc   +1 more source

Burden of long‐term conditions and management of people with overweight and obesity: Data from the United Kingdom primary care cohort of the IMPACT‐O study

Diabetes, Obesity and Metabolism, Volume 28, Issue 3, Page 1683-1692, March 2026.
Abstract Aims The multi‐country epIdeMiology landscape PAtient Care paThways of Obesity (IMPACT‐O) retrospective cohort study utilised existing electronic medical records to gather data on overweight and obesity. We report UK data on obesity‐related complications (ORCs) and management strategies.
Kamlesh Khunti, Matt Capehorn, Esther Artime, Lill‐Brith von Arx, Alun L. Davies, Atif Adam, Anastasia Lampropoulou   +6 more
wiley   +1 more source

Glucagon-Like Peptide-1 Receptor Agonists in the Prevention of Ischemic Stroke: Therapeutic Potential and Mechanisms. [PDF]

J Stroke
Lin Z, Li Z, Jia Q.
europepmc   +1 more source

Glucagon-like peptide-1 receptor agonists linked to a reduced risk of developing asthma among patients with type 2 diabetes. [PDF]

Ther Adv Endocrinol Metab
Cheng YS, Chung CH, Kuo SM, Lin CP, Weng TH, Su SC, Lu CH, Kuo FC, Chien WC, Liang YJ, Li PF.   +10 more
europepmc   +1 more source

Understanding the Role of Glucagon-like Peptide-1 Receptor Agonists in the Treatment of Heart Failure. [PDF]

Card Fail Rev
Bonfioli GB, Pagnesi M, Tomasoni D, Rakisheva A, Metra M.   +4 more
europepmc   +1 more source

Semaglutide and the Retina

Journal of Diabetes
Zachary T. Bloomgarden
doaj   +1 more source

Effects of Glucagon-Like Peptide-1 receptor agonists on bone health in people living with obesity. [PDF]

Osteoporos Int
Karam L, Mabilleau G, Paccou J.
europepmc   +1 more source

Prescribing Trends of Glucagon-Like Peptide 1 Receptor Agonists for Type 2 Diabetes or Obesity.

JAMA Netw Open
Li P, Varghese JS, Shah MK, Galindo RJ, Pasquel FJ, Ali MK, Shao H.   +6 more
europepmc   +1 more source

Emerging therapeutic potential of glucagon-like Peptide-1 receptor agonists in knee osteoarthritis: a systematic review. [PDF]

Front Pharmacol
Li Y, Yang L, Li F, Fu J, Zhao W, Wu X, Guo J, Yue C.   +7 more
europepmc   +1 more source